Clik here to view.
Arrowhead Receives Regulatory Approval to Begin Phase 2a Trial of Chronic...
PASADENA, Calif. Arrowhead Research Corporation (NASDAQ: ARWR), a biopharmaceutical company developing targeted RNAi therapeutics, today announced that it received regulatory approval to begin a...
View ArticleClik here to view.
BeiGene Announces Addition of Dr. Ronald Levy to Scientific Advisory Board
BEIJING BeiGene (Beijing), Co., Ltd., an innovative oncology company focused on developing targeted and immune-oncology therapeutics, today announced the addition of Dr. Ronald Levy, M.D., to its...
View ArticleClik here to view.
CTPartners Executive Search Inc. Acquires Australian Based Johnson Executive...
NEW YORK CTPartners Executive Search Inc. (NYSE MKT:CTP), a leading executive search firm, today announced that it has acquired Johnson Executive Search, the leading independent executive search...
View ArticleClik here to view.
BioTime Provides Financing and Product Development Update
ALAMEDA, Calif. BioTime, Inc. (NYSE MKT: BTX) today announced the results of its capital raising activities since October 1, 2013 through its $25 million Controlled Equity Offering facility, and...
View ArticleClik here to view.
昆泰在“国际罕见病日”指出全球共有3.5亿罕见病患者，同时发布了有关应对这一挑战的深入见解
北卡罗来纳州研究三角园区 (美国商业资讯)–在纪念今天的“国际罕见病日”，昆泰(Quintiles)指出全球共有3.5亿人患有罕见病——如果是个国家的话人数可排世界第三，同时重点介绍该公司在应对这一挑战方面的贡献，并推出了涵盖相关最新进展和深入观点的系列论文、播客和视频。...
View ArticleClik here to view.
Pharmaron Earns CFDA GLP Certification for Toxicology Facility
BEIJING Pharmaron announced today that the company’s GLP toxicology facilities in Beijing have earned a certificate of full GLP compliance from the Chinese Food and Drug Administration (CFDA) based...
View ArticleClik here to view.
（株）STC Life， 干细胞研究治疗中心成功治疗 脑中风患者
首尔, 韩国 (美国商业资讯)– (株) stclife（董事长：李桂浩）97.7生命科学研究院（院长：郑元柱），成功地使用间充质干细胞治疗了脑中风患者。 脑中风是大脑机能的部分或者全部，急促的障碍性疾病，持续时间长。除了脑出血之外，其他的诱发原因还没有找到。脑中风是由脑出血引发疾病的总称，一般是指会突然出现急促脑出血，意识模糊，肌肉麻痹的脑疾病。...
View ArticleClik here to view.
STC lifeが幹細胞研究治療センターで脳卒中患者の治療に成功
韓国・ソウル （ビジネスワイヤ） — STC Life Co., Ltd.（会長：KYE HO LEE)の幹細胞研究所と97.7 B&H Clinic（代表医師：WON JU JUNG）は、脳卒中患者の間葉系幹細胞治療を成功裏に完了しました。...
View ArticleClik here to view.
ハーラン・コントラクト・リサーチ・サービシズ（CRS）とBertin Pharmaが戦略的提携を発表
スイス・イティンゲン （ビジネスワイヤ） — ハーラン・コントラクト・リサーチ・サービシズと仏モンティニー・ル・ブルトンヌーのBertin Pharmaは、包括的な早期段階医薬品開発サービスを提供するための戦略的提携契約を締結しました。両社は、特に薬事申請関連の研究という点で、プロファイリングおよび分子検査の拡大を含め、以前にも増して広範な創薬と橋渡し研究のサービスを提供していきます。...
View ArticleClik here to view.
Harlan合同研究服务(CRS)公司与 Bertin Pharma宣布战略合作
瑞士伊廷根 （美国商业资讯）– Harlan合同研究服务公司和位于法国Montigny-le-Bretonneux的Bertin Pharma签订全方位早期药物研发服务战略合作关系。两家公司将提供广阔领域的药物发明和转化医学服务（包括拓展性能分析和分子检测），特别是在报批研究领域。 通过此次合作，Harlan CRS公司将利用Bertin...
View ArticleClik here to view.
Celerion Opens Operations in South Korea at Seoul National University...
LINCOLN, Neb. Celerion is pleased to announce the expansion of clinical operations to South Korea. Through partnership with Seoul National University Hospital (SNUH), the new Asian office is located...
View ArticleClik here to view.
STC life, Ltd. Successfully Treats Stroke Patients at Stem Cell Research...
SEOUL, South Korea Stem cell research institute of STC Life Co., Ltd. (Chairman: KYE HO LEE) and 97.7 B&H Clinic (Representative Doctor: WON JU JUNG) successfully completed mesenchymal stem cell...
View ArticleClik here to view.
加州大学旧金山分校与Verliant合作推动废物回收和废物转化可再生能源的发展
Smart Multimedia Gallery “Verliant has already made great strides in the microbial digestion of organic wastes and this research will allow us to refine and improve our process and take us to the...
View ArticleClik here to view.
3億5000万人の希少疾患患者に世界が目を向ける日に当たり、クインタイルズが課題に取り組むための詳細な検討成果を公開
米ノースカロライナ州リサーチ・トライアングル・パーク （ビジネスワイヤ） —...
View ArticleClik here to view.
Eisai and Biogen Idec Enter Collaboration to Develop and Commercialize...
TOKYO & CAMBRIDGE, Mass. Eisai Co., Ltd. (TSE: 4523) and Biogen Idec (NASDAQ: BIIB) announced today that they have entered into a collaboration to develop and commercialize two of Eisai’s...
View ArticleClik here to view.
Dr. Reddy’s Announces the Launch of Moxifloxacin Hydrochloride Tablets
HYDERABAD, India Dr. Reddy’s Laboratories Ltd. (NYSE: RDY) announced today that it has launched Moxifloxacin Hydrochloride Tablets, 400 mg, a therapeutic equivalent generic version of Avelox®...
View ArticleClik here to view.
NCKU Hosts Symposium to Explore Macromolecular Analysis
TAINAN, Taiwan “Now is really the perfect time in history for the university here in Tainan to jump into the field of cryo-EM (cryo-electron microscopy),” said Dr. Robert M. Glaeser, Professor...
View ArticleClik here to view.
Viva Biotech and HQL Pharmaceuticals Join Forces to Form Powerhouse for...
SHANGHAI & REHOVOT, Israel. Viva Biotech Ltd., a leading company in structure-based and fragment based drug discovery services, based in Shanghai, China, and HQL Pharmaceuticals Ltd., a drug...
View ArticleClik here to view.
Verastem Reports Data from Phase 1 Study of VS-6063 (defactinib) in Japanese...
CAMBRIDGE, Mass. Verastem, Inc. (NASDAQ: VSTM), focused on discovering and developing drugs to treat cancer by the targeted killing of cancer stem cells, today presented preliminary data from an...
View ArticleClik here to view.
日本人患者を対象にした VS-6063 ( defactinib ) の第1相試験のデータをVerastem社が発表
米国マサチューセッツ州ケンブリッジ （ビジネスワイヤ） — がん幹細胞の選択的殺傷によるがん治療の薬剤開発を中心に行っているVerastem 社 ( NASDAQ: VSTM ) は本日、日本人患者を対象に行われている VS-6063 ( defactinib )...
View Article